Objective: To determine the incidence of focal, late-onset, conjunctiv
al bleb leaks after glaucoma filtering surgery. Design: Prospective, c
ross-sectional analysis. Setting: Tertiary care outpatient referral ce
nter. Patients: Consecutive patients who underwent glaucoma filtering
surgery prior to June 1996 presenting for evaluation from September 2,
1996, through November 15, 1996. Five hundred twenty-five eyes of 525
consecutive patients were enrolled in the study. Intervention: Bleb h
eight (elevated or flat), area (diffuse or localized), and wall thickn
ess (thin, thick, or encapsulated) were classified. Each bleb was test
ed for focal leakage using a moistened fluorescein strip, cobalt blue
illumination, and slit-lamp biomicroscopy. Diffuse transconjunctival a
queous flow did not qualify as a focal leak. Main Outcome Measure: Sei
del-positive aqueous leakage. Results: Bleb leakage occurred in 14 eye
s following trabeculectomy (mitomycin C treatment, 10 eyes; 5-fluorour
acil treatment, 3 eyes; no antifibrosis agent, 1 eye) and in 1 eye fol
lowing combined cataract and glaucoma surgery with adjunctive mitomyci
n C therapy. Bleb leakage occurred more frequently in eyes that receiv
ed mitomycin C (10 [3.7%] of 273 eyes) than 5-fluorouracil (3 [1.4%] o
f 213 eyes) or no antifibrosis agent (1 [2.6%] of 39 eyes), using Kapl
an-Meier estimates (P=.008, log-rank test). Conjunctival blebs were si
gnificantly thinner after trabeculectomy with mitomycin C than with 5-
fluorouracil (P=.001). Bleb wall thickness was greater following combi
ned cataract and glaucoma surgery than following trabeculectomy alone
(P=.008). Age (P=.84), sex (P=.68), race (P=.77), duration of mitomyci
n C exposure (P=.62), number of antiglaucoma medications (P=.16), and
total 5-fluorouracil dose (P=.85) were not associated with late-onset
leaks. Conclusions: The risk of late-onset focal bleb leakage increase
s following trabeculectomy with mitomycin C therapy. Late leakage afte
r combined cataract and glaucoma surgery is infrequent.